BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29871519)

  • 21. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression.
    Howell JM; Lochmüller H; O'Hara A; Fletcher S; Kakulas BA; Massie B; Nalbantoglu J; Karpati G
    Hum Gene Ther; 1998 Mar; 9(5):629-34. PubMed ID: 9551611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A normal life without muscle dystrophin.
    Zatz M; Vieira NM; Zucconi E; Pelatti M; Gomes J; Vainzof M; Martins-Bach AB; Garcia Otaduy MC; Bento dos Santos G; Amaro E; Landini V; Andrade T
    Neuromuscul Disord; 2015 May; 25(5):371-4. PubMed ID: 25770920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological comparison of the smooth uterine muscle of healthy golden retriever bitches, carriers of the progressive muscular dystrophy (GRMD) gene, and GRMD-affected bitches.
    Brolio MP; Cima DS; Miglino MA; Ambrósio CE
    Anim Reprod Sci; 2014 Nov; 150(1-2):56-61. PubMed ID: 25200710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvessel density in muscles of dogs with golden retriever muscular dystrophy.
    Nguyen F; Guigand L; Goubault-Leroux I; Wyers M; Cherel Y
    Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.
    Araujo KP; Bonuccelli G; Duarte CN; Gaiad TP; Moreira DF; Feder D; Belizario JE; Miglino MA; Lisanti MP; Ambrosio CE
    PLoS One; 2013; 8(4):e61367. PubMed ID: 23579193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
    Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF
    J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy.
    Schatzberg SJ; Anderson LV; Wilton SD; Kornegay JN; Mann CJ; Solomon GG; Sharp NJ
    Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs.
    Dell'Agnola C; Wang Z; Storb R; Tapscott SJ; Kuhr CS; Hauschka SD; Lee RS; Sale GE; Zellmer E; Gisburne S; Bogan J; Kornegay JN; Cooper BJ; Gooley TA; Little MT
    Blood; 2004 Dec; 104(13):4311-8. PubMed ID: 15328150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The electroretinographic phenotype of dogs with Golden Retriever muscular dystrophy.
    Beltran WA; Chahory S; Gnirs K; Escriou C; Blot S; Clerc B
    Vet Ophthalmol; 2001 Dec; 4(4):277-82. PubMed ID: 11906664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tarsal joint contracture in dogs with golden retriever muscular dystrophy.
    Kornegay JN; Sharp NJ; Schueler RO; Betts CW
    Lab Anim Sci; 1994 Aug; 44(4):331-3. PubMed ID: 7983843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy.
    Barthélémy I; Pinto-Mariz F; Yada E; Desquilbet L; Savino W; Silva-Barbosa SD; Faussat AM; Mouly V; Voit T; Blot S; Butler-Browne G
    Dis Model Mech; 2014 Nov; 7(11):1253-61. PubMed ID: 25261568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.
    Fraysse B; Barthélémy I; Qannari EM; Rouger K; Thorin C; Blot S; Le Guiner C; Chérel Y; Hogrel JY
    BMC Musculoskelet Disord; 2017 Apr; 18(1):153. PubMed ID: 28403854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical therapy assessment tools to evaluate disease progression and phenotype variability in Golden Retriever muscular dystrophy.
    Gaiad TP; Silva MB; Silva GC; Caromano FA; Miglino MA; Ambrósio CE
    Res Vet Sci; 2011 Oct; 91(2):188-93. PubMed ID: 21315399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN; Peterson JM; Bogan DJ; Kline W; Bogan JR; Dow JL; Fan Z; Wang J; Ahn M; Zhu H; Styner M; Guttridge DC
    Skelet Muscle; 2014; 4():18. PubMed ID: 25789154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GRMD cardiac and skeletal muscle metabolism gene profiles are distinct.
    Markham LW; Brinkmeyer-Langford CL; Soslow JH; Gupte M; Sawyer DB; Kornegay JN; Galindo CL
    BMC Med Genomics; 2017 Apr; 10(1):21. PubMed ID: 28390424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
    BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Li J; Nghiem P; Detwiler DA; Larsen CA; Grange RW; Bhavaraju-Sanka RK; Tou S; Keene BP; Howard JF; Wang J; Fan Z; Schatzberg SJ; Styner MA; Flanigan KM; Xiao X; Hoffman EP
    Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy.
    Fan Z; Wang J; Ahn M; Shiloh-Malawsky Y; Chahin N; Elmore S; Bagnell CR; Wilber K; An H; Lin W; Zhu H; Styner M; Kornegay JN
    Neuromuscul Disord; 2014 Feb; 24(2):178-91. PubMed ID: 24295811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.